Quetiapine or placebo for depression with anxiety conditions
About this title
Read the official source — NCT00688818This study evaluated the effectiveness of Quetiapine for people with anxiety.
Understand this study
What did researchers investigate?
This study evaluated the effectiveness of Quetiapine for people with anxiety.
Who was this study for?
Listed age limits: 18 years to 65 years.
What did participation involve?
Depending on the group, the protocol specifies the study medication (quetiapine) or a placebo (an inactive comparison treatment).
- Listed locations
- Chatham and 3 more locationsSee all locations and recruitment
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 108
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00688818
- Official title
Show the full official title
Randomized, Placebo-Controlled Effectiveness Study of Quetiapine XR in Co-Morbid Depressive and Anxiety Disorders
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Chatham · Markham · Mississauga
1 more locations
- Toronto
Interested in joining this study?
Questions about this study
What did researchers investigate?
This study evaluated the effectiveness of Quetiapine for people with anxiety.
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Quetiapine and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
